Mylan Institutional, Inc. is recalling 7,515 cartons of Levothyroxine Sodium Tablets (levothyroxine) in various strengths because the medication may be subpotent (too weak) or superpotent (too strong). These prescription tablets are used to treat thyroid conditions and are sold in cartons containing 100 unit-dose blister cards. Taking medication that is not the correct strength can lead to ineffective treatment or dangerous levels of thyroid hormone in the body.
Subpotent or superpotent thyroid medication can cause uncontrolled thyroid levels, leading to serious health complications like hyperthyroidism or hypothyroidism. Potency deviations in thyroid drugs are particularly concerning because the body requires very precise levels of the hormone to function properly.
You have 2 options:
100 Tablets per carton (10 unit dose blister cards of 10 tablets each)
100 Tablets per carton (10 unit dose blister cards of 10 tablets each)
100 Tablets per carton (10 unit dose blister cards of 10 tablets each)
100 Tablets per carton (10 unit dose blister cards of 10 tablets each)
100 Tablets per carton (10 unit dose blister cards of 10 tablets each)
100 Tablets per carton (10 unit dose blister cards of 10 tablets each)
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.